Pabst Labs is opening a new manufacturing facility and distribution center dedicated to cannabis beverages in Desert Hot Springs, California.
The "cutting edge” facility will allow the company to more than triple its production capabilities.
According to Chuck Barlick, Pabst Labs' director of production, the goal is to leverage over twenty years of beverage manufacturing experience while establishing a standard for quality and efficiency that would set the bar in all cannabis-infused beverages facilities.
On top of its eponymous Pabst Blue Ribbon 10mg High Seltzer, the company also produces Not Your Father's Cannabis-Infused Root Beer and the St. Ides Cannabis product line.
Other brands will be allowed to access the facility through co-packaging relationships to help raise beverage quality and opportunity across the industry.
THC-infused beverages are seeing a 40 percent growth rate, the fastest-growing category in the cannabis industry, according to the Cannabis Beverage Association (CBA).
PBR High Seltzer is one of the top-selling THC-infused carbonated beverages in California.


Micron to Expand Memory Chip Manufacturing Capacity in Singapore Amid Global Shortage
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Asian Stock Markets Start New Year Higher as Tech and AI Shares Drive Gains
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
ASML’s EUV Monopoly Powers the Global AI Chip Boom
Why financial hardship is more likely if you’re disabled or sick
USDA $12 Billion Farm Aid Program Draws Mixed Reactions from Row Crop Farmers
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
Debate over H-1B visas shines spotlight on US tech worker shortages
Hyundai Motor Shares Slide After Trump Signals Higher U.S. Tariffs on South Korean Goods
Singapore GDP Growth Surges in 2025 but Outlook Remains Cautious Amid Global Trade Risks
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Asian Markets Slip as Precious Metals Cool, Geopolitical Tensions Weigh on Sentiment
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 



